Tiziana Life Sciences (TLSA) announced that its CEO, Ivor Elrifi, has purchased 163,400 shares of Tiziana common stock in the open market. This brings his current purchased shares total to 357,848.
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TLSA:
- Tiziana Life Sciences Withdraws Public Offering Amid Market Conditions
- Tiziana Life Sciences announces withdrawal of proposed public offering
- Tiziana Life Sciences Initiates Phase 2 Alzheimer’s Trial with Innovative Approach
- Tiziana Life Sciences to dose first patient in Phase 2 Alzheimer’s trial
- Tiziana Life Sciences Announces Spinout of IL-6 Asset into New Company